SARM1 is a metabolic sensor activated by an increased NMN/NAD+ ratio to trigger axon degeneration is a research paper published in Neuron (2021). On theSindex it has a DataRank of 0. It has been cited 339 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Computational Infrastructure
Grant: cj47
National Institutes of Health
Grant: R01CA219866
National Institutes of Health
Grant: RF1AG013730
National Institutes of Health
Grant: RO1NS087632
National Health and Medical Research Council
Grant: 1107804
Characterization and inhibition of higher-order assembly signalling in Toll-like receptor pathways
National Health and Medical Research Council
Grant: 1071659
Protein glycan interactions in infectious diseases.
National Health and Medical Research Council
Grant: 1160570
National Health and Medical Research Council
Grant: 1108859
Prion-like behaviour in immunity: super-sized signalling platforms?
Queensland Cyber Infrastructure Foundation
Grant: fi49
Australian Research Council
Grant: FL180100109
Australian Laureate Fellowships - Grant ID: FL180100109
NIDDK NIH HHS
Grant: P30 DK056341
NINDS NIH HHS
Grant: R01 NS087632
NIA NIH HHS
Grant: R01 AG013730
University of Queensland
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Genetic inactivation of SARM1 axon degeneration pathway improves outcome trajectory after experimental traumatic brain injury based on pathological, radiological, and functional measures
Additional file 1 of Genetic inactivation of SARM1 axon degeneration pathway improves outcome trajectory after experimental traumatic brain injury based on pathological, radiological, and functional measures
Additional file 1 of Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma
Additional file 2 of Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma
Additional file 2 of Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma
Additional file 1 of Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma